Q3 2024 Mentice AB Earnings Call Transcript
Key Points
- Mentice AB (OSTO:MNTC) reported a positive operational cash flow for the year-to-date, despite a negative cash flow for the quarter.
- The company launched two new products in the neurovascular area, which have been well-received and are expected to drive future growth.
- Mentice AB (OSTO:MNTC) experienced a strong performance in the APAC region, with a 4% increase in sales compared to last year.
- The hospital business segment showed significant growth, with a 30% increase compared to the same period last year.
- The company has a strong market presence, being the dominant simulation vendor at major medical conferences, which enhances its visibility and credibility in the industry.
- Mentice AB (OSTO:MNTC) reported a decline in net sales by 10% compared to the third quarter of last year.
- The company's EBITDA for the quarter was negative, at minus SEK 6.2 million, reflecting financial challenges.
- There was a decline in the order book by 9%, indicating potential future revenue challenges.
- The Americas and EMEA regions underperformed, with a 19% decline in sales in the EMEA region compared to last year.
- The variability in business performance, particularly in the MDI segment, has impacted the company's financial results.
Good morning and welcome everyone. My name is Richard Engberg and I'm an equity research analyst here at Carnegie. With me, I have Göran Malmberg, CEO of Mentice and Ulrika Drotz Voksepp, CFO of Mentice who are going to present the third quarter.
Welcome.
¶ -
Thank you.
So nice to be here. So I will dive right into the presentation.
So yeah, Ulrika Chief Financial Officer here.
So dive in so the third quarter, not entirely where we wanted, but still, I mean, slightly below last year. But we should also remember that this is on the back end of a record high second quarter. As a consequence of the top line. Obviously, the the profitability is also lower than, than expected where we had a negative FDA in the quarter. But a break even for the full year so far. We also have a positive cash flow, positive operational cash flow for year-to-date while negative in the quarter. And we should also remember, we talk about that a bit
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
